The response is what counts Treatment regimen intensity does not significantly impact survival outcomes in acute myeloid leukemia and myelodysplastic syndrome patients who achieve complete remission. Jan. 21, 2019 in Science Spotlight
US cancer death rate has declined for at least 25 years The U.S. cancer death rate has dropped 27 percent over the past 25 years. The encouraging stats come from the American Cancer Society’s latest annual report. Fred Hutch experts dive deeper into the data and explain how we can accelerate progress against cancer for everyone. Jan. 10, 2019 in Hutch News
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research Fred Hutch biostatistician Dr. James Dai recently was awarded a $2.1 million grant from the National Cancer Institute to develop new analytical methods for identifying genetic and epigenetic alterations that drive cancers. He hopes this work will facilitate the discovery of molecular cancer drivers — biomarkers — and the development of new preventive, diagnostic and prognostic techniques. Aug. 20, 2018 in Hutch News
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.